cytarabine and bisbenzimidazole

cytarabine has been researched along with bisbenzimidazole in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauer, W; Fritzer-Szekeres, M; Grusch, M; Hoechtl, T; Horvath, Z; Illmer, C; Krupitza, G; Mader, RM; Madlener, S; Saiko, P; Schott, H; Szekeres, T1
Erker, T; Fritzer-Szekeres, M; Handler, N; Horvath, Z; Jaeger, W; Murias, M; Saiko, P; Szekeres, T1

Other Studies

2 other study(ies) available for cytarabine and bisbenzimidazole

ArticleYear
Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.
    Nucleosides, nucleotides & nucleic acids, 2004, Volume: 23, Issue:8-9

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Bisbenzimidazole; Cell Line, Tumor; Colonic Neoplasms; Coloring Agents; Cytarabine; Dimerization; Dinucleoside Phosphates; Fluorescent Dyes; Fluorouracil; Humans; Inhibitory Concentration 50; Lymphoma; Propidium

2004
Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.
    Nucleosides, nucleotides & nucleic acids, 2006, Volume: 25, Issue:9-11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bisbenzimidazole; Cell Cycle; Cytarabine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Fluorescent Dyes; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Propidium; Pyrogallol; Stilbenes

2006